Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.
Latest
09:30 ET Servier Completes the Acquisition of Symphogen
Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S. Symphogen will...
09:30 ET IPP Announces AGC Biologics Acquisition of AstraZeneca Boulder, CO Plant
International Process Plants (IPP), a global buyer and seller of pharmaceutical and biopharmaceutical manufacturing facilities and equipment,...
09:00 ET IRIC broadens its ranks by recruiting David Knapp and Geneviève Deblois as new Principal Investigators
MONTREAL, June 4, 2020 /CNW Telbec/ - The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce...
07:30 ET ImmunoPrecise Collaborates with the NIH and Integrated Biotherapeutics to Study the Structural Details of Antibodies with Therapeutic Potential to Treat or Prevent Coronavirus Disease 2019 (COVID-19)
VICTORIA, BC, June 4, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF), a provider of best-in-class...
07:00 ET Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today provided a recap of a Key Opinion Leader (KOL) call sponsored by Canaccord Genuity and held ...
Jun 03, 2020, 10:00 ET Eleva's Drug Candidate to Be Examined for Use in COVID-19 Treatment
Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The...
Jun 03, 2020, 08:00 ET Avectas and UC Davis Collaborate on Cell Engineering Technology
Avectas today announced that it has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in...
Jun 03, 2020, 07:30 ET Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe
MISSISSAUGA, ON, June 3, 2020 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical...
Jun 03, 2020, 05:20 ET Norwegian EXACT Therapeutics Appoints Rafiq Hasan as CEO
EXACT THERAPEUTICS AS, a clinical stage precision medicine company utilizing Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today ...
Jun 02, 2020, 14:00 ET Precision Biomonitoring Receives Funding to Manufacture TripleLock™ SARS CoV-2 Go-Strips
Innovative Efforts Receive Funding from NGen In Response to Canadian Supply Development Support GUELPH, ON and MISSISSAUGA, ON, June 2, 2020 /CNW/ -...
Jun 02, 2020, 10:00 ET Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Scale Clinical Developmental Services
Based on its recent analysis of the Chinese contract research organizations (CROs) market, Frost & Sullivan recognizes Tigermed with the 2020 Chinese ...
Jun 02, 2020, 09:40 ET DERMALOG Fever Check at Clever Fit Gym
After a mandatory corona break of several weeks, sports facilities and fitness studios in Germany are reopening. Operators have to comply with...
Jun 02, 2020, 07:55 ET MyndTec Announces Partnership with SDVOSB Maness Veteran Medical to Distribute MyndMove™ to the US Department of Defense and The Department of Veterans Affairs
MISSISSAUGA, ON, June 2, 2020 /CNW/ - To improve access for US veterans and active duty military to the latest innovative technology, MyndTec, an...
Jun 02, 2020, 07:00 ET Neptune Appoints Robert DiPede as Senior Vice President of Biodroga and Health & Wellness Innovation
Former Walmart executive brings 20+ year proven track record of driving B2C and B2B sales of CPG and health and wellness products across all channels ...
Jun 02, 2020, 06:00 ET Cellenkos® Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome
Cellenkos Inc., a privately held, clinical stage biotech company announced today that the US Food & Drug Administration (FDA) has cleared the way to...
Jun 01, 2020, 17:55 ET Willow Biosciences Announces Annual General And Special Meeting Voting Results
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE ...
Jun 01, 2020, 15:32 ET IRIC's Emergency Fund: Thank you to all of our allies!
MONTREAL, June 1, 2020 /CNW Telbec/ - A few weeks ago, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal...
May 29, 2020, 17:30 ET Covalon Delays Filing of Interim Financial Statements Due to Delays Related to COVID-19 and Provides Business Update
MISSISSAUGA, ON, May 29, 2020 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical...
May 29, 2020, 17:00 ET Quest Provides Additional Information on OncoQuest Transaction and Announces Delay in Annual Filings
TSX Venture: QPT EDMONTON, May 29, 2020 /CNW/ - At the request of IIROC Market Surveillance, Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the...
May 29, 2020, 13:48 ET Nerium Biotechnology Provides Update on Status of its Q1 2020 Filings - Announces Reliance on Temporary Regulatory Filing Relief
SAN ANTONIO, TX, May 29, 2020 /CNW/ - Nerium Biotechnology, Inc. (the "Company") is providing an update on the status of its interim condensed...
May 29, 2020, 10:21 ET BIOREM Announces Delay in Filing Interim Financial Statements
GUELPH, ON, May 29 2020 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") announces that due to circumstances created by the Covid-19...
May 28, 2020, 17:30 ET Liminal BioSciences to present at Jefferies Virtual Healthcare Conference
LAVAL, QC, and CAMBRIDGE, United Kingdom, May 28, 2020 /CNW Telbec/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or...
May 28, 2020, 16:15 ET SQI Diagnostics Inc. Announces Director Changes
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/ TORONTO, May 28, 2020 /CNW/ - SQI Diagnostics...
May 28, 2020, 09:15 ET SQI Diagnostics Reports Second Quarter 2020 Results
TORONTO, May 28, 2020 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational...
May 28, 2020, 01:30 ET CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical...
